Varenicline for Smoking Cessation in Heavy Drinking Smokers

Conditions

Heavy Drinking | Nicotine Dependence | Smoking

What is the purpose of this trial?

The purpose of this study is to determine whether extended pretreatment with varenicline (Chantix) is more efficacious for smoking cessation than standard pretreatment, how well varenicline is tolerated in heavy drinking smokers, and whether varenicline reduces alcohol consumption.



Participation Guidelines

Age:
18 Years - 75 Years
Gender:
Both

Click here for detailed information about who can participate in this trial.


Sponsor:
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Yale University
Dates:
October 2008
Last Updated:
January 28, 2013
Study HIC#:
0809004276

Clinicaltrials.gov ID: NCT00860028